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Editorial

A Simple Estimate for Extracellular Volume:
Too Simple?
Guido Filler* and Shih-Han S. Huang†

Clin J Am Soc Nephrol 6: 695– 696, 2011. doi: 10.2215/CJN.01340211

Extracellular volume (ECV) is the body water outside
cells. It is also the volume of distribution of endogenous markers used for measuring GFR. Traditionally,
GFR is calculated in children in relation to body surface area (BSA). Among the various BSA formulas
used in most countries, the DuBois formula [BSA ⫽
0.007184 ⫻ H0.725 ⫻ W0.425] is the standard (1). This
complicated formula requires a scientific calculator;
therefore, many clinicians use the much more simple
Mosteller formula [BSA ⫽ 公(H ⫻ W/3600)] instead
(2), which can be calculated using simple calculators.
The use of BSA for the estimation of GFR has been
criticized for leading to inaccurate estimates, especially in children. Several other variables correlate to
GFR and have been considered instead of BSA, including weight (3,4), the square of height (4), lean
body mass (5,6), total body water (7), and plasma
volume (8). However, several groups, particularly Dr.
Peter’s group from Cambridge, proposed normalizing GFR to ECV instead (9). Interestingly, pediatric
studies in this area are rare. These methods require
adequate calculations based on the volume of distribution of the isotope injected, using appropriate nonlinear
two-compartment models. In Europe, 51chromiumethylenediamine tetra-acetic acid (51Cr-EDTA) is the
most commonly used method, whereas in North America, the 99m-technetium diethylene triamine penta-acetic
acid (99mTc-DTPA) is used most commonly, but iohexol
can be used instead. When conducted carefully, ECV
can be measured directly during the GFR scan (10,11).
Recently, the large pediatric National Institutes of
Health–funded study assessed children with mild to
moderate chronic kidney disease (CKD; Chronic Kidney
Disease in Children [CKiD] Study; GFR range 30 to 90
ml/min per 1.73 m2) in 43 participating centers (12). In
that study, GFR was measured carefully with appropriate plasma disappearance curves using a two-compartment model after iohexol injection. Abraham et al. (13)
used these 790 iohexol studies from the CKiD Study to
determine the volume of distribution from the GFR
scan. ECV was in the expected range (interquartile
range 5.9 to 12.2 L). They elegantly showed that ECV
could be simply calculated on the basis of square root of
weight (kg) multiplied by the height (m). As expected,
ECV strongly correlated with BSA on the log scale. This
formula is certainly more applicable than the older ECV
formulas (14).
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Not only is the study by Abraham et al. (13) very
helpful for the easy determination of ECV, but also the
practicing pediatric nephrologists cannot overemphasize the importance of estimating the ECV. Even though
the study by Abraham et al. (13) failed to demonstrate an
association between ECV and BP, volume-overloaded
patients tend to have higher BP, especially those with
advanced CKD with or without dialysis. BP may also be
related to renin and angiotensin activation in patients
with CKD, which may be independent of volume status.
There may also be third-spacing of fluid. Another kidney disease associated with alteration of the ECV, either
over- or underfill, is frequently seen in patients with
nephrotic syndrome.
Another potential advantage is the hope to have a
better normalization of GFR. Any biomarker of GFR
demonstrates considerable scatter when plotted against
the measured GFR, especially in the high GFR range.
There is always the question of what causes this. We
recently demonstrated that the effect of hyperfiltration is
significant but small when creatinine is used (15), rendering creatnine an inferior marker of GFR estimation.
On the other hand, the concentration of markers such as
cystatin C (small volume of distribution mainly in ECV)
varies substantially and can increase in a dialysis session
if a substantial amount of ultrafiltration occurs with a
reduction of the ECV (16), which reduces the feasibility
of cystatin C as a GFR marker independent of ECU. It is
hoped that investigators study the question of whether
the scatter can be reduced when normalizing GFR to
ECV rather than BSA.
To date, only a few other formulas for the estimation of ECV exist, such as the Bird’s ECV formula
(ECV ⫽ weight0.6469 ⫻ height0.7236 ⫻ 0.02154) (14) or
the older Friis-Hansen estimate (17). They also use
height and weight but require a scientific calculator
for their calculation. By contrast, Abraham’s ECV
formula provides a relatively simple approach to
calculate ECV. So why does ECV estimation matter?
Peters et al. (9) suggested that GFR should be normalized to ECV. Using this simple estimation may
allow further study of the question of whether normalizing GFR to ECV rather than BSA is more
feasible. Moreover, the volume of distribution can
now be assessed more accurately and may assist in
the determination of dry weight and diuretics prescription. It is hoped that the scatter of endogenous
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Figure 1. | Bland-Altman plot: Bias of individual estimated ECV
equations.

markers, especially in the high GFR range, can be reduced if it is normalized to ECV (18).
It would be important to validate these findings against
different measures of volume status, such as bioimpedance, inferior vena cava diameter, and other tools (19). For
similar validations purposes, the authors could have been
randomly split the group into a two-thirds data generation
set and a one-third data validation set for internal validation of the formula, as is frequently done for similar questions (20). A comparison with other equations would also
have been helpful.
Using our own data set, we compared the Bird’s ECV
formula with the proposed Abraham’s ECV formula. We
found a good correlation using Spearman rank correlation
with coefficient of 0.9988 (95% confidence interval 0.9985 to
0.9991). However, the agreement (Bland-Altman analysis)
was less than perfect with a systematic overestimation of
the new Abraham formula (Figure 1). The percentage bias
was 6.83% [100 ⫻ (Abraham’s ECV ⫺ Bird’s ECV)/average
ECV] with a 95% confidence interval between 0.119 and
13.543%. It is important to note that without having the
gold standard ECV measurements, Bland-Altman analysis
studies only the agreement between formulas but does not
assist with determining which is correct.
It will remain to be established how robust this new
formula will be when validated in future studies, adult
populations, and dialysis patients. An assessment in special populations such as hyperfiltering patients who have
diabetes and are early in the course of diabetic nephropathy or obese patients who have normal ECV would also be
helpful. Intuitively, using lean body weight may serve as a
better parameter for ECV estimation when compared with
total body weight.
Nonetheless, 95 years after Dubois and Dubois published
the standard BSA formula, Abraham’s formula derived from
the carefully conducted CKiD Study provides a simple tool
for estimation of ECV that has previously been missing.
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